Molecular Templates Future Growth
Future criteria checks 0/6
Molecular Templates's revenue and earnings are forecast to decline at 43% and 4.4% per annum respectively while EPS is expected to grow by 45.6% per annum.
Key information
-4.4%
Earnings growth rate
45.6%
EPS growth rate
| Biotechs earnings growth | 31.1% |
| Revenue growth rate | -43.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Aug 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 6 | -70 | -62 | N/A | 1 |
| 12/31/2024 | 14 | -49 | -53 | N/A | 2 |
| 12/31/2023 | 50 | -22 | -22 | N/A | 2 |
| 6/30/2023 | 50 | -47 | -73 | -72 | N/A |
| 3/31/2023 | 48 | -60 | -84 | -81 | N/A |
| 12/31/2022 | 20 | -93 | -92 | -89 | N/A |
| 9/30/2022 | 35 | -81 | -97 | -93 | N/A |
| 6/30/2022 | 33 | -87 | -98 | -93 | N/A |
| 3/31/2022 | 44 | -78 | -104 | -100 | N/A |
| 12/31/2021 | 39 | -83 | -34 | -30 | N/A |
| 9/30/2021 | 24 | -101 | -35 | -29 | N/A |
| 6/30/2021 | 26 | -94 | -30 | -24 | N/A |
| 3/31/2021 | 18 | -110 | -30 | -23 | N/A |
| 12/31/2020 | 19 | -105 | -91 | -84 | N/A |
| 9/30/2020 | 22 | -92 | -56 | -48 | N/A |
| 6/30/2020 | 21 | -107 | -57 | -45 | N/A |
| 3/31/2020 | 19 | -85 | -42 | -32 | N/A |
| 12/31/2019 | 22 | -69 | -35 | -25 | N/A |
| 9/30/2019 | 21 | -60 | -27 | -20 | N/A |
| 6/30/2019 | 24 | -27 | -16 | -13 | N/A |
| 3/31/2019 | 20 | -28 | -11 | -6 | N/A |
| 12/31/2018 | 13 | -30 | -10 | -4 | N/A |
| 9/30/2018 | 9 | -31 | -38 | -32 | N/A |
| 6/30/2018 | 3 | -36 | -32 | -26 | N/A |
| 3/31/2018 | 2 | -31 | -24 | -21 | N/A |
| 12/31/2017 | 3 | -24 | -16 | -14 | N/A |
| 9/30/2017 | 3 | -20 | -8 | -7 | N/A |
| 6/30/2017 | 2 | -13 | -7 | -6 | N/A |
| 3/31/2017 | 3 | -11 | N/A | -10 | N/A |
| 12/31/2016 | 2 | -13 | N/A | -9 | N/A |
| 12/31/2015 | 1 | -7 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NZW is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NZW is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NZW is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NZW's revenue is expected to decline over the next 3 years (-43% per year).
High Growth Revenue: NZW's revenue is forecast to decline over the next 3 years (-43% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NZW's Return on Equity is forecast to be high in 3 years time